Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Currently, Jean-Paul Kress is Chairman at ERYTech Pharma SA, CEO & Chairman-Management Board at MorphoSys AG and President & Director at Syntimmune, Inc.

He previously was President-International & Executive Vice President at Biogen, Inc., President & Chief Executive Officer at Sanofi Pasteur MSD SNC and Senior Vice President & Head-North America at Genzyme Corp.

Dr. Kress received an undergraduate degree and a graduate degree from École Normale Supérieure and a doctorate from Faculté De Médecine Necker Enfants Malades Université.


Current positions of Jean-Paul Kress 
NameTitle Since
MorphoSys AG
(Biotechnology & Medical Research)
CEO & Chairman-Management Board 2019
ERYTECH Pharma S.A.
(Biotechnology & Medical Research)
Chairman 2019
Syntimmune, Inc. President & Director -


Jean-Paul Kress: Personal Network 
Most Read News 
07/27AMANCIO ORTEGA : Inditex founder Ortega buys 5% in Enagas's renewable, hydrogen unit
RE
07/29MARK ZUCKERBERG : Company's pandemic-era forecast was too rosy
RE
07/26MARK ZUCKERBERG : As Zuckerberg bets on TikTok-style videos, Meta heads for first-ever revenue drop
RE
07/29CATHIE WOOD : Wood's ARK fund on track for first monthly gain since Oct as risky stocks rally
RE
08/06ELON MUSK : Musk says Twitter deal should go ahead if it provides proof of real accounts
RE
08/02ELON MUSK : Twitter queries banks on Musk's attempts to undermine $44 billion deal
RE
07/26ELON MUSK : Elon Musk asks judge for Twitter trial on Oct. 17, not Oct. 10
RE
08/04JACK DORSEY : Dorsey-led Block posts loss for second quarter
RE
07/28JACK MA : Jack Ma plans to give up control of Ant Group - WSJ
RE
08/01DAVID EINHORN : Einhorn's Greenlight takes stake in Twitter - letter
RE
More news


© 2022 People and Ownership :   
Jean-Paul Kress : Connections